Dolastatin 15 from a Marine Cyanobacterium Suppresses HIF‐1α Mediated Cancer Cell Viability and Vascularization
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dolastatin 15 from a Marine Cyanobacterium Suppresses HIF‐1α Mediated Cancer Cell Viability and Vascularization
Authors
Keywords
-
Journal
CHEMBIOCHEM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-04-02
DOI
10.1002/cbic.202000180
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in Exploring the Therapeutic Potential of Marine Natural Products
- (2019) Xiao Liang et al. PHARMACOLOGICAL RESEARCH
- Glucocorticoids promote Von Hippel Lindau degradation and Hif-1α stabilization
- (2017) Andrea Vettori et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drugs and Drug Candidates from Marine Sources: An Assessment of the Current “State of Play”
- (2016) David Newman et al. PLANTA MEDICA
- Genome-wide mapping of Hif-1α binding sites in zebrafish
- (2015) David Greenald et al. BMC GENOMICS
- Targeted Natural Products Discovery from Marine Cyanobacteria Using Combined Phylogenetic and Mass Spectrometric Evaluation
- (2015) Lilibeth A. Salvador-Reyes et al. JOURNAL OF NATURAL PRODUCTS
- Caldora penicillatagen. nov., comb. nov. (Cyanobacteria), a pantropical marine species with biomedical relevance
- (2015) Niclas Engene et al. JOURNAL OF PHYCOLOGY
- Trimmomatic: a flexible trimmer for Illumina sequence data
- (2014) Anthony M. Bolger et al. BIOINFORMATICS
- The first cyanobacterial infection of crustose coralline algae discovered on the reefs of Pohnpei, Micronesia
- (2014) Greta S Aeby et al. BULLETIN OF MARINE SCIENCE
- Mechanism of mitotic arrest induced by dolastatin 15 involves loss of tension across kinetochore pairs
- (2013) Manu Lopus MOLECULAR AND CELLULAR BIOCHEMISTRY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody–drug conjugates
- (2012) Diego A. Gianolio et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
- (2011) Bo Li et al. BMC BIOINFORMATICS
- Veraguamides A−G, Cyclic Hexadepsipeptides from a Dolastatin 16-Producing CyanobacteriumSymplocacf.hydnoidesfrom Guam
- (2011) Lilibeth A. Salvador et al. JOURNAL OF NATURAL PRODUCTS
- von Hippel-Lindau tumor suppressor mutants faithfully model pathological hypoxia-driven angiogenesis and vascular retinopathies in zebrafish
- (2010) E. van Rooijen et al. Disease Models & Mechanisms
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
- (2009) M. D. Robinson et al. BIOINFORMATICS
- Zebrafish mutants in the von Hippel-Lindau tumor suppressor display a hypoxic response and recapitulate key aspects of Chuvash polycythemia
- (2009) E. van Rooijen et al. BLOOD
- Targeting both HIF-1 and HIF-2 in human colon cancer cells improves tumor response to sunitinib treatment
- (2009) K. Burkitt et al. MOLECULAR CANCER THERAPEUTICS
- Activation of HIF-1α in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway
- (2008) Frédéric Dayan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- High-resolution in situ hybridization to whole-mount zebrafish embryos
- (2007) Christine Thisse et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now